0001628280-24-025999.txt : 20240531 0001628280-24-025999.hdr.sgml : 20240531 20240531144318 ACCESSION NUMBER: 0001628280-24-025999 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240529 FILED AS OF DATE: 20240531 DATE AS OF CHANGE: 20240531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Farid Ramy CENTRAL INDEX KEY: 0001797707 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 241009139 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 1800 OWENS STREET STREET 2: SUITE 900 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 wk-form4_1717180989.xml FORM 4 X0508 4 2024-05-29 0 0001706431 Vir Biotechnology, Inc. VIR 0001797707 Farid Ramy C/O VIR BIOTECHNOLOGY, INC. 1800 OWENS STREET, SUITE 900 SAN FRANCISCO CA 94158 1 0 0 0 0 Common Stock 2024-05-29 4 A 0 16000 0 A 16000 D Stock Option (Right to Buy) 10.10 2024-05-29 4 A 0 16000 0 A 2034-05-28 Common Stock 16000 16000 D Stock Option (Right to Buy) 10.10 2024-05-29 4 A 0 16000 0 A 2034-05-28 Common Stock 16000 16000 D 1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter. Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders. /s/ Vanina de Verneuil, Attorney-In-Fact 2024-05-31